Every 12 seconds someone in the world is killed by medical error, this industry now kills people almost as fast as tobacco and cancer does. But we call this healthcare? Around 9 million people work in this industry all over the world but it kills almost how many it employs per year in all parts of the world too. Communism didnt even kill people that fast or warfare and people were punished for those crimes but today nobody is held responsible like before. You cause evil you belong in evil!! Ethernity in Hell awaits all who profit and live off others suffering
Our Blog Detail
- Author: admin
- 0 Comments
Novartis Pharmaceutical Corp. will pay $678 million to the U.S. government and various states to settle a lawsuit over a sham speaker program that distributed cash, expensive dinners and other treats to induce doctors to prescribe its products, federal authorities announced Wednesday. The settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on “speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis’s drugs.” Messages seeking comment were left with lawyers for Novartis Pharmaceuticals, which is part of Swiss drug manufacturer Novartis International AG. PFIZER, MYLAN, NOVARTIS SUED BY U.S. ATTORNEYS GENERAL FOR PRICE-FIXING, ANTITRUST VIOLATIONS Vas Narasimhan, chief executive of Novartis, said in a statement that the company has already changed, “with new leadership, a stronger culture, and a more comprehensive commitment to ethics embedded at the heart of our company.” “With these agreements we mark an important milestone on our journey to build trust with society as we continue re-imagining medicine to improve and extend lives all around the world,” Narasimhan said.
Bayer has agreed to settle thousands of US lawsuits claiming that its widely-used weedkiller Roundup caused cancer for as much as $10.9 billion after more than a year of talks, resolving litigation that has hit the company's share price. The German drugs and pesticides maker has come to terms with about 75% of the current Roundup plaintiffs, involving about 125,000 filed and unfiled claims overall, it said in a statement on the deal to end legal disputes it inherited with its $63 billion takeover of Monsanto in 2018. The settled cases over Roundup and other glyphosate-based weedkillers account for about 95% of those currently set for trial, Bayer added. "The Roundup settlement is the right action at the right time for Bayer to bring a long period of uncertainty to an end," chief executive Werner Baumann said. The company added it will make a payment of $8.8-$9.6 billion to resolve the current Roundup litigation, including an allowance expected to cover unresolved claims, and $1.25 billion to support a separate class agreement to address potential future litigation. Ken Feinberg, who was appointed settlement mediator by a federal judge more than a year ago, said that while nearly 25,000 claims remained unsettled there will be no more trials as cases settle in coming months. "Bayer wisely decided to settle the litigation rather than roll the dice in American court," said Mr Feinberg, who has mediated other high-profile disputes, including over the 9/11 Victim Compensation Fund, the BP Deepwater Horizon disaster and Volkswagen's diesel emissions scandal. Bayer said in February that it did not need to write down Monsanto's value in its books if it has to spend $10 billion on a settlement, reflecting the average analyst estimate at the time. The company, whose management in April regained shareholder support for its handling of the litigation, has denied claims that Roundup or its active ingredient glyphosate causes cancer, saying decades of independent studies have shown the product is safe for human use. Bayer said it expects to maintain its investment grade credit ratings and intends to keep its dividend policy. Monsanto began selling Roundup in 1974, and while the formulation is no longer patent protected, Roundup remains widely available. Bayer will continue selling Roundup and will not add a cancer warning label to the product, a company spokesman said. Bayer has repeatedly said Roundup is safe and important to farmers who use the herbicide in combination with the company's genetically modified seeds.
IRELAND`S 2040 PLANS Project Ireland 2040 aims to provide balanced regional development, in order to reduce Dublin’s growing economic domination, and to improve the State’s infrastructure. It seeks to plan for where the anticipated one million extra people who will be living in the State 25 years from now will be housed, work and go to school. It consists of two plans. The National Planning Framework (NPF) will decide how to achieve balanced regional development. It will prioritise growth in the major cities of Dublin, Cork, Galway, Limerick and Waterford, although the capital is forecast to grow at a slower rate under this plan. The second strand is the National Development Plan (NDP), a 10-year, €115 billion programme to upgrade State infrastructure in anticipation of the population increase. About €90 billion of the plan will come from taxpayers, with the remainder expected to come from commercial State-owned enterprises.
Purdue and other drug companies have been forced to pay out hundreds of millions of dollars so far in civil lawsuits, which currently number more than 2,000 across the U.S. Prosecutors say evidence shows these firms pushed highly addictive opioid pain medication while downplaying the risk of addiction and overdose. They say executives engaged in racketeering and conspiracy, misleading doctors, insurance companies and government programs such as Medicare and Medicaid But the legal action has largely remained in the civil sphere, and Rose thinks it's time for prosecutors to start treating drug companies as criminal enterprises for their role in an epidemic that — according to the Centers for Disease Control and Prevention — claimed nearly 400,000 lives between 1999 and 2017.
Officials at troubled drugmaker Purdue Pharma say “certain employees” should be paid more than $34 million in bonuses for meeting and exceeding goals over the last three years, even though the company is facing thousands of lawsuits over its role in the nation’s opioid crisis and earlier this week filed for bankruptcy. In a legal filing, attorneys for Purdue Pharma asked a judge to authorize millions in payments to employees who have met “target performance goals.” It is not clear from the company filings why employees would be eligible for bonuses because, while the bonuses are supposed to be partly contingent on the company’s financial performance, the company has filed for bankruptcy. [Purdue Pharma's bankruptcy plan includes special protection for the Sackler family fortune] At a bankruptcy court hearing in White Plains, N.Y., on Tuesday, Paul K. Schwartzberg, an attorney for the U.S. Trustee, raised objections to some of the bonuses. While it is typical for companies in bankruptcy to try to pay employees as a firm seeks to regain its financial footing, the Purdue Pharma bonuses go “way beyond” what is typical, he said.
Irish doctors are urged to stop over-prescribing benzodiazepines and similar drugs That council has warned that over-prescriptions of the drugs is affecting the safety of Irish patients. THE MEDICAL COUNCIL has warned that doctors who are caught over-prescribing benzodiazepines, z-drugs and Pregabalin will face disciplinary action. The council is seeking to take action on the issue at national level, as it believes that the over-prescription of the drugs is negatively affecting the safety of patients. Benzodiazepines are a group of medicines that can be prescribed for short periods to help with sleeping problems, or to help with episodes of severe anxiety. They are not for long-term use, and can be dangerous if a patient develops an overreliance or a dependency on them. President of the Medical Council, Dr Rita Doyle said that inappropriate prescribing of benzodiazepines, z-drugs, Pregabalin and other controlled drugs is having a significant impact on patient safety and wellbeing.
Purdue Pharma on Sunday filed for Chapter 11 bankruptcy, part of a deal to settle thousands of lawsuits alleging the company misled doctors and the public as it promoted its opioid painkillers, including its blockbuster OxyContin, and helped ignite the opioid epidemic killing more than the Vietnam war within a few decades by prescription. so what happens now? 12billion offer for 400000 deaths in a few decades? The idea is to produce a resolution in a faster, more focused manner than would be the case in civil court. And even if plaintiffs only receive a fraction of what they are owed, the aim is to get everyone a piece of the pie. Otherwise, different plaintiffs might try to accelerate their own efforts so they can take the full amount owed to them, leaving little for other plaintiffs. “If [a company] has to pay cases as they were finalized, the plaintiff that had reached a resolution in its case earlier might get paid in full, but there would be nothing left for anyone else,” said Jesse Fried, a professor at Harvard Law School. States that have opposed the bankruptcy deal have said that it would not extract enough from members of the Sackler family. They’ve argued that Purdue’s assets are limited because the family has absorbed the bulk of the company’s profits, and so should be on the hook for more than the deal outlines. On Friday, the New York attorney general’s office said it had uncovered $1 billion in wire transfers by the Sacklers, alleging the family was trying to hide its assets. In 2007, Purdue and company executives agreed to pay $634.5 million to settle federal allegations that the company had misbranded OxyContin. The company and three executives also pleaded guilty to criminal charges. In March, Purdue and the Sacklers agreed to pay $270 million to settle a case brought by the state of Oklahoma. Plaintiffs’ attorneys have likened the ongoing case to the one against the tobacco industry that culminated in a $246 billion settlement two decades ago.
Stamford, Connecticut — CBS News has learned the billionaire Sackler family, who own Purdue Pharma, are willing to give up ownership of the company and pay an additional $3 to $4.5 billion from their personal wealth to settle more than 2,000 lawsuits accusing the drug maker of fueling the opioid crisis. The settlement offer comes amid speculation that Purdue Pharma is about to go bankrupt. Over two decades, while the sale of the painkiller Oxycontin generated billions in profits for the drugmaker, the nation's opioid addiction was reaching a crisis. According to the U.S. Centers for Disease Control and Prevention, overdose deaths linked to prescription opioids have killed more than 218,000 Americans since the late 1990s. Tony LaGreca's son Matthew died in 2014 after a long struggle with prescription opioids. He said his addiction started with a single bottle of Purdue Pharma's Oxycontin to treat a football injury. "They're offering a certain amount of money. And first of all the amount of money is way too small," LaGreca said. "There's still millions of people who now are still fighting addiction. And that addiction has come from the initial prescription from opioids." Meanwhile, a threat of bankruptcy looms. A source close to negotiations say there's no timing on a potential filing. But CBS News has learned Purdue has given plaintiffs a deadline of Wednesday to accept the deal, or it will file for bankruptcy.
Authorities have identified about $1 billion in wire transfers between the owners of pharmaceutical giant Purdue Pharma, the entities they control and different financial institutions, New York Attorney General Letitia James said Friday. The discovery of the wire transfers comes as amid growing allegations by New York and other states that the Sackler family is moving billions of dollars offshore to protect their wealth. It also follows news two days ago of a proposed settlement by Purdue Pharma to thousands of states, counties, cities and tribal governments in their ongoing lawsuit accusing the company of fueling the nation's opioid epidemic. The New York attorney general's office is trying to determine how much money the Sacklers have amassed and where it is. Details about the wire transfers, including some that authorities say were funneled through Swiss bank accounts, were released as part of a new court filing by Attorney General James in the ongoing lawsuit.
IRISH DOCTORS ARE prescribing increasing amounts of the same highly addictive painkillers associated with a health epidemic in the United States. Figures seen by TheJournal.ie show that prescriptions of 10 powerful opioids – a class of drug whose derivatives include morphine and heroin – rose by almost 20% in nine years. In 2009, doctors in Ireland issued 1,463,359 prescriptions for fentanyl, oxycodone, mephedrene, hydrocodone, morphine, codeine, percocet, hydromorphone, oxymorphone and tramadol. In 2017, that figure rose to 1,739,110 prescriptions, while 715,699 prescriptions for the drugs were issued across the country in the first six months of this year. These drugs were a factor in the deaths of almost 200 people a day in the US last year, and prompted Donald Trump to declare a national health emergency last October. Does the recent rise in prescriptions here mean Ireland should be worried about an opioid crisis of its own? dam right it should when over 700 a year die from drug deaths with most of them related to pharmaceuticals and many suicides also related to pharmaceuticals. yet every hour of the day we only hear about road safety when these kill nearly 4 times as many as road deaths per year in Ireland and no doctors are going to prison for this murder!!
From AlterNet: “Big Pharma’s trail of greed, power, and cruelty gets worse every year. Its products and practices take hundreds of thousands of lives in the U.S. from over-prescriptions, lethal combinations of prescriptions, ineffective or contaminated drugs, and dangerous side-effects. The biggest drug dealers in the U.S. operate legally. Their names are emblazoned in ads and promotions everywhere. Who hasn’t heard of Eli Lilly, Merck, Pfizer, and Novartis? Big Pharma revenues and profits have skyrocketed. In 2017, the U.S. consumers spent $333.4 billion on prescription drugs. . . . The FDA weakly regulates drugs, which are supposed to be both safe and effective, before they can be sold. Who funds this FDA effort? The drug industry itself—required by a law it has learned to love . . . Big Pharma’s greatest strength is its hold over Congress. That is where it gets its huge bundle of subsidies and monopolistic privileges . . . The great hands-on humanitarian organisation Doctors Without Borders, operating in 70 countries often under dangerous armed conflicts, lists ‘Six Things Big Pharma Doesn’t Want You to Know’ in its recent alert letter. They are: Costs of developing new medicines are exaggerated tenfold or more. You’re paying twice for your medicines—first as taxpayers and second as consumers or through your government programs. Drug companies are not that good at innovation. About two thirds of new drugs (called ‘me-too drugs’) are no better, and may be riskier, than the ones already in pharmacies. But they are advertised as special. Monopoly patents are extended by clever lawyers to block more affordable generic versions. This maneuver is called ‘ever greening.’ Pharma bullies low and middle income countries like South Africa, Thailand, Brazil, Colombia, and Malaysia that try to curb its rapaciousness. These drug companies use trade rules and the U.S. government towards their brutal goals. In the 1990s, a small group of consumer advocates led by Jamie Love, Bill Haddad, and Robert Weissman persuaded Cipla, an Indian drug firm, and Ministries of Public Health to lower the price of AIDS medicines from $10,000 per patient per year price down to $300 (now under $100). The U.S. drug companies were quite willing to let millions die because they couldn’t pay. Big Pharma always says they have to have large profits to pay for R&D and innovation. Really? Why then do they spend far more on stock buybacks (one of the metrics for executive compensation), on marketing and advertising than on R&D? Dr. Wolfe exposed this malarkey years ago. Yet exposure has not stopped the worsening behaviour of Big Pharma. Good books by Katharine Greider (The Big Fix) and Dr. Marcia Angell (The Truth About the Drug Companies) are devastating critiques of Big Pharma’s practices. Despite this, the books reach small audiences and are brushed off by the drug giants. Big Pharma is able to ignore these books because it controls most of Congress—candidates rely heavily on the industry for campaign budgets. But the American people outnumber the drug companies and only the people can actually vote come election time. Focused voters mean more to politicians than campaign money. The August recess for Congress means your lawmakers are back home having personal meetings. Visit them and make known your demands against the ‘pay or die’ industry. Tell them your own stories.”
Purdue Pharma offers $10 billion to $12 billion to settle opioid claims Laura Strickler 8/27/2019 Weary Bahamas evacuees arrive in Florida Brown agrees to 1-year contract with Patriots Purdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion. The potential deal was part of confidential conversations and discussed by Purdue's lawyers at a meeting in Cleveland last Tuesday, Aug. 20, according to two people familiar with the mediation. Brought by states, cities and counties, the lawsuits — some of which have been combined into one massive case — allege the company and the Sackler family are responsible for starting and sustaining the opioid crisis. At least 10 state attorneys general and the plaintiffs’ attorneys gathered in Cleveland, where David Sackler represented the Sackler family, according to two people familiar with the meeting. David Sackler, who was a board member of the company, has recently been the de facto family spokesperson. The lawsuits that Purdue and the Sacklers are seeking to settle allege that their company’s sales practices were deceptive and at least partly responsible for the opioid crisis, which claimed more than 400,000 lives from 1999 to 2017, according to the Centers for Disease Control and Prevention. Some of the lawsuits also allege that after 2007 the Sackler family drained the company of money to enrich themselves. “The Sackler family built a multibillion-dollar drug empire based on addiction,” New Jersey Attorney General Gurbir Grewal said in May when his state joined others in suing the Sackler family and their company. Massachusetts Attorney General Maura Healey was the first to name family members in her suit in January. Purdue Pharma, which makes the opioid painkiller OxyContin, and the Sackler family have denied the allegations laid out in the lawsuits. In a statement to NBC News, the company said: "While Purdue Pharma is prepared to defend itself vigorously in the opioid litigation, the company has made clear that it sees little good coming from years of wasteful litigation and appeals." "The people and communities affected by the opioid crisis need help now. Purdue believes a constructive global resolution is the best path forward, and the company is actively working with the state attorneys general and other plaintiffs to achieve this outcome," the company added. A representative for the Sackler family did not respond to a request for comment. the only word for these type of people are Psychopaths!!
THE HSE HAS paid out over €832 million on medical negligence cases since 2014, newly released figures show. Payouts have totalled €108 million for the first five months of 2019. In the past five years payouts have increased by 365%, jumping from €59 million in 2014 to €215 million in 2018. Fianna Fáil TD for Galway East, Anne Rabbitte, who obtained the figures, said they raise concerns about what the HSE is doing to limit such negligence in the first place, particularly at a time when health spending is spiralling. “I don’t think the recipients of these payouts are being acquisitive, they undoubtedly deserve this money. Negligent actions can sometimes leave people dealing with issues for years to come and they deserve to be compensated, Last year, Clinical director of the HSE’s national women and infant health programme, Dr Peter McKenna said preventable brain damage in normally formed infants is the “single biggest risk” in the health service. He said negligence in maternity cases makes up more than half of the payouts made by the State, adding that the onus is on the health service to investigate as early as possible how these injuries are caused during childbirth. Earlier this year, Health Minister Simon Harris said all options must be explored in seeking an alternative mechanism for resolving clinical negligence claims, one which is more person-centered, but fair to all parties. The minister has also indicated that a mandatory open disclosure policy for health workers will be enshrined in law by the end of the year. Open disclosure ensures staff must communicate with patients and their families when things go wrong with their care.
the medical mafia is now killing people around the world faster than all wars combined do each year, and almost as fast as aids does per year worldwide. that clearly states that the pharmaceutical industry now has cancer from profiting off greed for decades and is causing cancer to the whole world and their health. if aids is so dangerous and a terrible thing to live with. what does that make big pharma to go through then when its killing people by profiting from their sickness and getting away with it for decades. another way to look at it is this. in 2009 Ireland was forced to pay 60 billion in a bailout package and it caused over a decade of Austerity and hundreds of thousands to leave and debt to sky rocket that it will take decades to pay back and have those youth today living far worse than their parents generation did. since 2009 big pharmaceuticals have all been fined 40 billion for the mafia crimes and Opioid crisis they have killed off from profit and this is only the beginning now of bringing these firms to justice for the cancer epidemic they have caused worldwide.
Johnson & Johnson fined $572 million for fueling opioid crisis Oklahoma's attorney general accused Johnson & Johnson of a "multi-billion-dollar brainwashing campaign" to get doctors to overprescribe opioids, downplaying the addiction risks. J&J shares surged after the ruling. Logo of US pharmaceutical company Johnson & Johnson A judge in the US state of Oklahoma found health care giant Johnson & Johnson responsible for fueling the opioid addiction crisis in the state. The company will have to pay $572.1 million (€515 million) to Oklahoma in compensation. The Oklahoma case against Johnson & Johnson is one of more than 2,000 complaints that have been brought up by municipalities against drugmakers over opioid abuse nationwide. According to Oklahoma's Attorney General Mike Hunter, 4,653 people were killed in opioid-related deaths from 2007 to 2017. Hunter said Johnson & Johnson created "the worst man-made public health crisis in the history of our country and the state," accusing the company of carrying out a "multi-billion-dollar brainwashing campaign" to get doctors to overprescribe the drug. Read more: Opioids in Africa: cheap and accessible Funds for addiction treatment Oklahoma's is the first legal case to successfully bring a pharmaceutical giant to trial for the opioid crisis and win. Prosecutors argued that the company marketed opioids aggressively for years, by overstating their effectiveness and downplaying the addiction risk. Judge Thad Balkman said prosecutors successfully demonstrated that the company contributed to a "public nuisance" through its deceptive advertisement of highly addictive prescription painkillers. "Those actions compromised the health and safety of thousands of Oklahomans," Balkman said. The prosecution had sought $17 million in compensation, but Balkman said the case was not strong enough for such a figure. According to the ruling, the compensation money will go to funding an "abatement plan" for care for addicts, families and communities ravaged by the crisis. Read more: Britain's opioid crisis takes on US dimension The company said it would appeal the decision, arguing that the law was being inappropriately applied and that its products had a very small role in the opioid epidemic. "The unprecedented award for the state's 'abatement plan' has sweeping ramifications for many industries and bears no relation to the company's medicines or conduct," said Johnson & Johnson Executive Vice President Michael Ullmann. The success of the Oklahoma case could provide hope for other states. Attorneys for the plaintiffs in Ohio called the Oklahoma judgment "a milestone amid the mounting evidence against the opioid pharmaceutical industry." "While public nuisance laws differ in every state, this decision is a critical step forward for the more than 2,000 cities, counties, and towns we represent in the consolidation of federal opioid cases," they said in a statement. jcg/aw (dpa, Reuters, AFP, AP) Watch video 01:41 Johnson & Johnson tried for allegedly causing an "opioid epidemic" Each evening at 1830 UTC, DW's editors send out a selection of the day's hard news and quality feature journalism. You can sign up to receive it directly here. DW recommends Data shows slight drop in US drug overdose deaths Drug overdose deaths in the US have dropped for the first time in two decades, according to preliminary data. The drop was due to a decline in deaths from prescription opoid painkillers. (18.07.2019) Cocaine, opium production hits record highs: UN The UN has warned of record levels of drug use and production across the globe. But cocaine and opium aren't the only problem: pharmaceutical opioids are also having a devastating effect. (26.06.2018) Opioids in Africa: cheap and accessible Cheap painkillers are the new drugs for the people. On the African continent, more and more people are becoming addicted and the illicit trade in pharmaceuticals is on the rise. (26.06.2019) Britain's opioid crisis takes on US dimension Opioid addiction in Britain has spiraled to a dangerous level. Experts warn that the UK is approaching a crisis of US proportions. What's the government doing to tackle the problem? Charlotte Potts reports from London. (19.05.2019) Landmark US opioid trial begins in Oklahoma Consumer products giant Johnson & Johnson has gone on trial in Oklahoma over its contribution to the state's opioid crisis. The case could set a precedent for thousands of other US lawsuits against drug manufacturers. (29.05.2019) WWW links DW Newsletter Audios and videos on the topic Johnson & Johnson tried for allegedly causing an "opioid epidemic" Date 27.08.2019 Keywords US, Oklahoma, pharmaceuticals, opioids, opioid epidemic Feedback: Send us your feedback. Print Print this page Permalink https://p.dw.com/p/3OXKu Related content Johnson & Johnson tried for allegedly causing an "opioid epidemic" 29.05.2019 One of the world's largest drug manufacturers, has gone on trial in a multi-billion dollar lawsuit by the US state of Oklahoma. Prosecutors accuse Johnson & Johnson of deceptively marketing painkillers and belittling addiction risks. By doing so, they say the company caused an "opioid epidemic" - that will cost the state up to 17 billion dollars to remedy. USA Ohio - Bewusstlose Eltern nach Überdosis Heroin mit Kind im Auto Data shows slight drop in US drug overdose deaths 18.07.2019 Drug overdose deaths in the US have dropped for the first time in two decades, according to preliminary data. The drop was due to a decline in deaths from prescription opoid painkillers. Symbolbild Mogelpackung Landmark US opioid trial begins in Oklahoma 28.05.2019 Consumer products giant Johnson & Johnson has gone on trial in Oklahoma over its contribution to the state's opioid crisis. The case could set a precedent for thousands of other US lawsuits against drug manufacturers.
For more accurate information on the type of blogging we do, Go to our page on Facebook exposing Big Pharma ( Independence From Pharmaceutical Maintenance )
The main preoccupation of society is to keep society sick!You use your inner resource it is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change, congratulations, you manage to break away...I would like to think you had at list one caring, adult. People who break out of the intergenerational transmission of abuse often have one warm, caring adult in their background .It's is so easy to become lost in the noise of life, to lose sight of ourselves.I am aware for many years of the psychotropic abuse because I suggested to a friend must be another way of getting herself well for 35 years she was prescribing drugs, I would mind this person is a nurse by profession.The psychiatrist was dismissive of my suggestion about keep fit exercise.A few years ago a different psychiatrist serving the community in Swords a young lady under his care was found dead in her bed she was under psychotropic drugs.The hope of humanity lies in the prevention of degenerative diseases, not in the care of their symptoms.I am planning the next few months to do exercise program it is effective as medication or therapy will be free for people who like to do exercise at home.Exercise has no negative effects.I alway wonder why doctors instantly prescribe antidepressant It is not just taking of antidepressants that can cause extreme violence.Withdrawal from antidepressants can cause extreme violence too.No one in any kind of profession can succeed unless he or she loves hi s job.Professor of social work Jerome Wakefield said in a 2012 interview that we've thrown tens of billions of dollars into trying to identify biomarkers and biological substrates for mental disorders the fact is we've gotten very little out of all that.Statistics show that except in the case of getting run over or ending an emergency caesarean Orthodox western medicine not only won't cure you but may leave you worse off than before.